Search

Start Over Keyword HIGH-THROUGHPUT

  • A clade C HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaques

    A clade C HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaques
    Authors:Anumita Sahoo, Emory UniversityAndrew T Jones, Emory UniversityNarayanaiah Cheedarla, Emory UniversitySailaja Gangadhara, Emory UniversityVicky Roy, Ragon Institute of MGH, MIT, and HarvardTiffany M Styles, Emory UniversityAyalnesh Shiferaw, Emory UniversityKorey L Walter, Louisiana State UniversityLaTonya D Williams, Duke UniversityXiaoying Shen, Duke UniversityGabriel Ozorowski, Scripps Research InstituteWen-Hsin Lee, Scripps Research InstituteSamantha Burton, Emory UniversityLasnajak Yi, Emory UniversityXuezheng Song, Emory UniversityZhaohui Qin, Emory UniversityCynthia Derdeyn, Emory UniversityAndrew B Ward, Scripps Research InstituteJohn D Clements, Tulane UniversityRaghavan Varadarajan, Indian Institute of ScienceGeorgia D Tomaras, Duke UniversityPamela A Kozlowski, Louisiana State UnivGalit Alter, Ragon Inst MGH MIT & HarvardRama Amara, Emory University
    Date:2022
    Publisher:AMER ASSOC ADVANCEMENT SCIENCE
    Publication Version:Author Accepted Manuscript (After Peer Review)
    License:Creative Commons Attribution 4.0 International

  • Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates

    Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates
    Authors:Joseph R Francica, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaBarbara J Flynn, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaKathryn E Foulds, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaAmy T Noe, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaAnne P Werner, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaIan Moore, Emory UniversityMatthew Gagne, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaTimothy S Johnston, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaCourtney Tucker, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaRachel L Davis, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaBritta Flach, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaSarah O'Connell, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaShayne F Andrew, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaEvan Lamb, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaDillon R Flebbe, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaSaule T Nurmukhambetova, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaMitzi M Donaldson, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaJohn-Paul M Todd, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaAlex Lee Zhu, MITCaroline Atyeo, MITStephanie Fischinger, MITMatthew J Gorman, MITSally Shin, MITVenkata Viswanadh Edara, Childrens Healthcare Atlanta & Emory UnivKatharine Floyd, Childrens Healthcare Atlanta & Emory UnivLilin Lai, Emory UniversitySeyhan Boyoglu-Barnum, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaRenee Van de Wetering, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaAlida Tylor, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaElizabeth McCarthy, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaValerie Lecouturier, Sanofi PasteurSophie Ruiz, Sanofi PasteurCatherine Berry, Sanofi PasteurTimothy Tibbitts, Sanofi PasteurHanne Andersen, BIOQUAL Inc.Anthony Cook, BIOQUAL Inc.Alan Dodson, BIOQUAL Inc.Laurent Pessaint, BIOQUAL Inc.Alex Van Ry, BIOQUAL Inc.Marguerite Koutsoukos, GSKCindy Gutzeit, GSKI-Ting Teng, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaTongqing Zhou, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaDapeng Li, Duke UniversityBarton F Haynes, Duke UniversityPeter D Kwong, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaAdrian McDermott, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaMark G Lewis, BIOQUAL Inc.Tong Ming Fu, Sanofi PasteurRoman Chicz, Sanofi PasteurRobert van der Most, GSKKizzmekia S Corbett, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaMehul Suthar, Emory UniversityGalit Alter, MITMario Roederer, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaNancy J Sullivan, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaDaniel C Douek, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaBarney S Graham, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaDanilo Casimiro, Sanofi PasteurRobert A Seder, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda
    Date:2021
    Publisher:AMER ASSOC ADVANCEMENT SCIENCE
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International

  • Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials

    Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials
    Authors:Stephanie Fischinger, Ragon Institute of MGH, Harvard and MGHDeniz Cizmeci, Ragon Institute of MGH, Harvard and MGHDavy Deng, University of California BerkeleyShannon P Grant, Fred Hutchinson Cancer Research CenterNicole Frahm, Fred Hutchinson Cancer Research CenterJulie McElrath, Fred Hutchinson Cancer Research CenterJonathan Fuchs, San Francisco Department of Public HealthPierre-Alexandre Bart, University of LausanneGiuseppe Pantaleo, University of LausanneMichael Keefer, University of RochesterWilliam O Hahn, University of WashingtonNadine Rouphael, Emory UniversityGavin Churchyard, Aurum Institute, ParktownZoe Moodie, Fred Hutchinson Cancer Research CenterYeycy Donastorg, Inst Dermatol & Cirugia Piel IDCPHendrik Streeck, University of Duisburg EssenGalit Alter, Ragon Institute of MGH, Harvard and MGH
    Date:2021
    Publisher:PUBLIC LIBRARY SCIENCE
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International

  • Targeting HIV Env immunogens to B cell follicles in nonhuman primates through immune complex or protein nanoparticle formulations.

    Targeting HIV Env immunogens to B cell follicles in nonhuman primates through immune complex or protein nanoparticle formulations.
    Authors:Jacob T. Martin, Koch Institute for Integrative Cancer ResearchChristopher A. Cottrell, Scripps Research InstituteAleksandar Antanasijevic, Scripps Research InstituteDiane G. Carnathan, Scripps Research InstituteBenjamin J. Cossette, Koch Institute for Integrative Cancer ResearchChiamaka A. Enemuo, Yerkes National Primate Research CenterEtse H. Gebru, Yerkes National Primate Research CenterYury Choe, Yerkes National Primate Research CenterFederico Viviano, Yerkes National Primate Research CenterStephanie Fischinger, Massachusetts General HospitalTalar Tokatlian, Koch Institute for Integrative Cancer ResearchKimberly M. Cirelli, Scripps Research InstituteGeorge Ueda, Department of Biochemistry, University of Washington, Seattle, WA, 98195, USA.Jeffrey Copps, Scripps Research InstituteTorben Schiffner, Scripps Research InstituteSergey Menis, Scripps Research InstituteGalit Alter, Massachusetts General HospitalWilliam R. Schief, Scripps Research InstituteShane Crotty, Scripps Research InstituteNeil P. King, University of WashingtonDavid Baker, University of WashingtonGuido Silvestri, Emory UniversityAndrew B. Ward, Scripps Research InstituteDarrell J. Irvine, Koch Institute for Integrative Cancer Research
    Date:2020
    Publisher:Emory University Libraries
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International

  • Targeting HIV Env immunogens to B cell follicles in nonhuman primates through immune complex or protein nanoparticle formulations

    Targeting HIV Env immunogens to B cell follicles in nonhuman primates through immune complex or protein nanoparticle formulations
    Authors:Jacob T. Martin, MITChristopher A. Cottrell, Scripps Research InstituteAleksandar Antanasijevic, Scripps Research InstituteDiane G. Carnathan, Scripps Research InstituteBenjamin J. Cossette, MITChiamaka A. Enemuo, Emory UniversityEtse H. Gebru, Emory UniversityYury Choe, Emory UniversityFederico Viviano, Emory UniversityStephanie Fischinger, Massachusetts General HospitalTalar Tokatlian, MITKimberly M. Cirelli, Scripps Research InstituteGeorge Ueda, University of WashingtonJeffrey Copps, Scripps Research InstituteTorben Schiffner, Scripps Research InstituteSergey Menis, Scripps Research InstituteGalit Alter, Massachusetts General HospitalWilliam R. Schief, Scripps Research InstituteShane Crotty, Scripps Research InstituteNeil P. King, University of WashingtonDavid Baker, University of WashingtonGuido Silvestri, Emory UniversityAndrew B. Ward, Scripps Research InstituteDarrell J. Irvine, MIT
    Date:2020
    Publisher:NATURE RESEARCH
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International

  • HIV Is Associated with Modified Humoral Immune Responses in the Setting of HIV/TB Coinfection

    HIV Is Associated with Modified Humoral Immune Responses in the Setting of HIV/TB Coinfection
    Authors:Esther van Woudenbergh, Ragon InstituteEdward B. Irvine, Ragon InstituteLeela Davies, Ragon InstituteMarwou de Kock, University of Cape TownWillem A. Hanekom, University of Cape TownCheryl Day, Emory UniversitySarah Fortune, Ragon InstituteGalit Alter, Ragon Institute
    Date:2020
    Publisher:AMER SOC MICROBIOLOGY
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International

  • Identification of rare DNA variants in mitochondrial disorders with improved array-based sequencing

    Identification of rare DNA variants in mitochondrial disorders with improved array-based sequencing
    Authors:Wenyi Wang, Stanford UniversityPeidong Shen, Stanford UniversitySreedevi Thiyagarajan, Stanford UniversityShengrong Lin, Stanford UniversityCurtis Palm, Stanford UniversityRita Horvath, Newcastle UniversityThomas Klopstock, University of MunichDavid Cutler, Emory UniversityLynn Pique, Stanford UniversityIris Schrijver, Stanford UniversityRonald W. Davis, Stanford UniversityMichael Mindrinos, Stanford UniversityTerence P. Speed, University of California BerkeleyCurt Scharfe, Stanford University
    Date:2011
    Publisher:Oxford University Press (OUP): Policy C - Option B
    Publication Version:Final Published Version
    License:Creative Commons Attribution-NonCommercial 2.5 Generic

  • Ligands for Glaucoma-Associated Myocilin Discovered by a Generic Binding Assay

    Ligands for Glaucoma-Associated Myocilin Discovered by a Generic Binding Assay
    Authors:Susan D. Orwig, Georgia Institute of TechnologyPamela V. Chi, Georgia Institute of TechnologyYuhong Du, Emory UniversityShannon E. Hill, Georgia Institute of TechnologyMarchello A. Cavitt, Georgia Institute of TechnologyAmrithaa Suntharalingam, University of South FloridaKatherine C. Turnage, Georgia Institute of TechnologyChad A. Dickey, University of South FloridaStefan France, Georgia Institute of TechnologyHaian Fu, Emory UniversityRaquel L. Lieberman, Georgia Institute of Technology
    Date:2014
    Publisher:American Chemical Society
    Publication Version:Author Accepted Manuscript (After Peer Review)

  • Microfluidic Transduction Harnesses Mass Transport Principles to Enhance Gene Transfer Efficiency

    Microfluidic Transduction Harnesses Mass Transport Principles to Enhance Gene Transfer Efficiency
    Authors:Reginald Tran, Emory UniversityDavid Myers, Emory UniversityGabriela Denning, Expression Therapeutics LLCJordan E. Shields, Emory UniversityAllison M. Lytle, Emory UniversityHommood Alrowais, Georgia Institute of TechnologyYongzhi Qiu, Emory UniversityYumiko Sakurai, Emory UniversityWilliam C. Li, Georgia Institute of TechnologyOliver Brand, Georgia Institute of TechnologyJoseph Le Doux, Emory UniversityH Trent Spencer, Emory UniversityChristopher Doering, Emory UniversityWilbur Lam, Emory University
    Date:2017
    Publisher:Elsevier (Cell Press): 12 month embargo
    Publication Version:Final Published Version
    License:Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

  • A Functional Role for Antibodies in Tuberculosis

    A Functional Role for Antibodies in Tuberculosis
    Authors:Lenette L. Lu, Ragon InstituteAmy W. Chung, Ragon InstituteTracy Rosebrock, Harvard School of Public HealthMusie Ghebremichael, Ragon InstituteWen Han Yu, Ragon InstitutePatricia S. Grace, Ragon InstituteMatthew K. Schoen, Ragon InstituteFikadu Tafesse, Ragon InstituteConstance Martin, Harvard School of Public HealthVivian Leung, Harvard School of Public Health
    Date:2016
    Publisher:Elsevier (Cell Press)
    Publication Version:Author Accepted Manuscript (After Peer Review)